Grant: Discovery Grants Program - Individual
University of Alberta
$27,000.00
Understanding the role of bacterial toxins on the etiology and pathogenesis of metabolic diseases and developing new strategies for their prevention in dairy cattle
FY 2012-13
Summary
Dairy cows often are affected by one or multiple metabolic and infectious diseases immediately after parturition. This is associated with high veterinary bills, lower productivity and longevity, and greater culling rate in most dairy herds. As a consequence, the dairy farm profitability and sustainability are affected considerably. Recent research conducted by our team and others suggests that Gram-negative bacterial (GNB) toxin, known as lipopolysaccharide (LPS), is involved in the etiology and pathogenesis of several metabolic diseases like fatty liver, displaced abomasum, laminitis, downer cow syndrome, and milk fat depression. Lipoteichoic acid (LTA), another bacterial toxin that is released from Gram-positive bacteria (GPB), also might be involved in disease pathogenesis. GNB and GPB infections often co-exist and synergistic interaction of their bacterial toxins, LPS and LTA, might produce metabolic and clinical conditions of even greater severity than infection with a single pathogen. There are no data regarding the role of LTA in pathogenesis of periparturient disorders in dairy cattle. Both GNB and GPB are present in large numbers in the gastrointestinal (GI) tract and are involved in infection of the uterus and mammary gland. The mechanistic details of how LPS and LTA influence health and productivity of dairy cattle are not fully known yet. For this reason, it is anticipated that understanding their role in disease and exploring new strategies for prevention of their deleterious effects will improve health and productivity of dairy cattle. Overall, the proposed research activities address important issues related to health and productivity of periparturient dairy cows. Results obtained will serve as a basis for early diagnosis of multiple diseases in transition dairy cows and for developing new strategies for their prevention. Successful conduction of the aforementioned research activities would benefit Canadian producers by providing new preventative interventions for enhancing animal longevity and productivity and lowering the expenses needed to maintain animal health. In addition, the proposed research will benefit Canadian consumers that will be provided dairy products deriving from healthier dairy cows.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
312019-2010
Name nom
Ametaj, Burim
Department département
Agricultural, Food and Nutritional Science
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
27000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
3
Nb partie
5
Application title
Understanding the role of bacterial toxins on the etiology and pathogenesis of metabolic diseases and developing new strategies for their prevention in dairy cattle
Keyword
NSERC
Application summary
Dairy cows often are affected by one or multiple metabolic and infectious diseases immediately after parturition. This is associated with high veterinary bills, lower productivity and longevity, and greater culling rate in most dairy herds. As a consequence, the dairy farm profitability and sustainability are affected considerably. Recent research conducted by our team and others suggests that Gram-negative bacterial (GNB) toxin, known as lipopolysaccharide (LPS), is involved in the etiology and pathogenesis of several metabolic diseases like fatty liver, displaced abomasum, laminitis, downer cow syndrome, and milk fat depression. Lipoteichoic acid (LTA), another bacterial toxin that is released from Gram-positive bacteria (GPB), also might be involved in disease pathogenesis. GNB and GPB infections often co-exist and synergistic interaction of their bacterial toxins, LPS and LTA, might produce metabolic and clinical conditions of even greater severity than infection with a single pathogen. There are no data regarding the role of LTA in pathogenesis of periparturient disorders in dairy cattle. Both GNB and GPB are present in large numbers in the gastrointestinal (GI) tract and are involved in infection of the uterus and mammary gland. The mechanistic details of how LPS and LTA influence health and productivity of dairy cattle are not fully known yet. For this reason, it is anticipated that understanding their role in disease and exploring new strategies for prevention of their deleterious effects will improve health and productivity of dairy cattle. Overall, the proposed research activities address important issues related to health and productivity of periparturient dairy cows. Results obtained will serve as a basis for early diagnosis of multiple diseases in transition dairy cows and for developing new strategies for their prevention. Successful conduction of the aforementioned research activities would benefit Canadian producers by providing new preventative interventions for enhancing animal longevity and productivity and lowering the expenses needed to maintain animal health. In addition, the proposed research will benefit Canadian consumers that will be provided dairy products deriving from healthier dairy cows.